150 related articles for article (PubMed ID: 32652700)
1. Steroid-sparing maintenance immunosuppression is safe and effective after simultaneous liver-kidney transplantation.
Weeks SR; Luo X; Toman L; Gurakar AO; Naqvi FF; Alqahtani SA; Philosophe B; Cameron AM; Desai NM; Ottmann SE; Segev DL; Garonzik-Wang J
Clin Transplant; 2020 Oct; 34(10):e14036. PubMed ID: 32652700
[TBL] [Abstract][Full Text] [Related]
2. Steroid avoidance or withdrawal for kidney transplant recipients.
Pascual J; Zamora J; Galeano C; Royuela A; Quereda C
Cochrane Database Syst Rev; 2009 Jan; (1):CD005632. PubMed ID: 19160257
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
Liu YY; Li CP; Huai MS; Fu XM; Cui Z; Fan LL; Zhang S; Liu Y; Ma J; Li G; Shen ZY
PLoS One; 2015; 10(3):e0120939. PubMed ID: 25816221
[TBL] [Abstract][Full Text] [Related]
4. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study.
Nehus EJ; Liu C; Lu B; Macaluso M; Kim MO
Nephrol Dial Transplant; 2017 Aug; 32(8):1424-1431. PubMed ID: 28810723
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression Regimen Use and Outcomes in Older and Younger Adult Kidney Transplant Recipients: A National Registry Analysis.
Lentine KL; Cheungpasitporn W; Xiao H; McAdams-DeMarco M; Lam NN; Segev DL; Bae S; Ahn JB; Hess GP; Caliskan Y; Randall HB; Kasiske BL; Schnitzler MA; Axelrod DA
Transplantation; 2021 Aug; 105(8):1840-1849. PubMed ID: 33214534
[TBL] [Abstract][Full Text] [Related]
6. National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection.
Axelrod DA; Naik AS; Schnitzler MA; Segev DL; Dharnidharka VR; Brennan DC; Bae S; Chen J; Massie A; Lentine KL
Am J Transplant; 2016 Aug; 16(8):2453-62. PubMed ID: 26901466
[TBL] [Abstract][Full Text] [Related]
7. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
[TBL] [Abstract][Full Text] [Related]
8. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.
Luan FL; Steffick DE; Ojo AO
Transplantation; 2011 Feb; 91(3):334-41. PubMed ID: 21242885
[TBL] [Abstract][Full Text] [Related]
9. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
Helal I; Chan L
Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
[TBL] [Abstract][Full Text] [Related]
10. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
13. Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens.
Krämer BK; Krüger B; Mack M; Obed A; Banas B; Paczek L; Schlitt HJ
Transplant Proc; 2005 May; 37(4):1789-91. PubMed ID: 15919467
[TBL] [Abstract][Full Text] [Related]
14. Induction type and outcomes for kidney graft and patient survival in recipients with prior lung transplantation in the United States.
Riad S; Goswami U; Jackson S; Hertz M; Matas A
J Heart Lung Transplant; 2020 Feb; 39(2):157-164. PubMed ID: 31837899
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid elimination in simultaneous liver-kidney transplantation recipients.
Weber NK; Wiseman AC; Trotter JF
Clin Transplant; 2009; 23(6):958-63. PubMed ID: 19664017
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Tacrolimus-Based Steroid Sparing versus Steroid Maintenance Regimens in Kidney Transplantation: Results from Discrete Event Simulation.
Desai VCA; Ferrand Y; Cavanaugh TM; Kelton CML; Caro JJ; Goebel J; Heaton PC
Med Decis Making; 2017 Oct; 37(7):827-843. PubMed ID: 28384413
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of crossmatch positive simultaneous liver-kidney transplantations in the United States.
Riad S; Aby ES; Nguyen PL; Jackson S; Lim N; Lake J
Liver Transpl; 2022 Sep; 28(9):1509-1520. PubMed ID: 35182001
[TBL] [Abstract][Full Text] [Related]
18. New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation.
Ulsh PJ; Yang HC; Holman MJ; Ahsan N
J Transpl Coord; 1999 Jun; 9(2):114-8. PubMed ID: 10703393
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Kidney Allograft and Recipient Survival After Liver Transplantation by Induction Type in the United States.
Riad SM; Lim N; Jackson S; Matas AJ; Lake J
Liver Transpl; 2021 Nov; 27(11):1553-1562. PubMed ID: 34145949
[TBL] [Abstract][Full Text] [Related]
20. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function.
Chang GJ; Mahanty HD; Vincenti F; Freise CE; Roberts JP; Ascher NL; Stock PG; Hirose R
Clin Transplant; 2000 Dec; 14(6):550-4. PubMed ID: 11127307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
